Journal Club
Author(s) -
Markus Niemeyer,
Johannes Ettl,
Birgit Plattner,
Rainer Schmid,
Daniel Müller,
HansGünther Machens,
M. Kiechle,
Stefan Paepke,
Kuo-Chun Liao,
Wen-Ying Lee,
Ming-Jenn Chen,
Emel Alimoğlu,
Kağan Çeken,
Adnan Kabaalioğlu,
Enrico Cassano,
Timur Sindel,
Ravikanth Balaji,
K. Ramachandran,
Volkmar Müller,
Peter Dubsky,
Tanja Fehm,
Florian Fitzal,
Jens Huober,
Marcus Schmidt,
Günther Steger,
Pedro Oscar R. Cunha,
Mark Ornstein,
J. Louise Jones,
Astrid Hacker,
Stefan Sedlacek,
Heinz Höfler,
Christoph Thomssen,
Nadia Harbeck,
Sylvia H. HeywangKöbrunner,
Jörg Nährig,
HansPeter Sinn,
Zeinab Elsawaf,
Birgit Helmchen,
Sebastian Aulmann,
Annette Lebeau,
Thorsten Kühn,
on behalf of the AGO Breast Committee
Publication year - 2010
Publication title -
breast care
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.767
H-Index - 30
eISSN - 1661-3805
pISSN - 1661-3791
DOI - 10.1159/000319790
Subject(s) - medicine , journal club , mastectomy , radiation therapy , clinical trial , schedule , medical physics , oncology , randomized controlled trial , breast cancer , cancer , pathology , computer science , operating system
Whole breast irradiation (WBI) is considered standard of care among both patients having undergone breast-conserving therapy for invasive breast carcinoma and selected cases post mastectomy. Since the introduction of WBI, clinical trials have been conducted to define the optimal dose, schedule and length of WBI aiming to increase efficacy while reducing toxicity. In the paper discussed in this issue's journal club, Whelan et al. present the latest in a series of randomized clinical trials on hypofractionated radiotherapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom